Manoj P. Jadhav, PhD, FCP

Founder and CEO

Translational Clinical Pharmacologist

Dr. Jadhav is responsible for strategic, scientific planning and business functions for the organization.

Dr. Jadhav brings more than twelve years of experience in academic and industry research, pharmaceutical development and regulatory affairs experience in US, India with small molecules and peptides therapeutics.

Before starting this company, he served as the Vice President clinical development and business strategy at CRC Pharma based in Parsippany, New Jersey. He has contributed to several drug development programs for both NCEs and 505(b)((2) across different therapeutics areas.

Dr. Jadhav has represented the Sponsors at the US-FDA for several pre-IND meetings, at the Division of Anti-infectives, Cardiovascular and Renal products, CNS, Dermatology, Pharmaceutical Quality, Oncology etc.

He is a trained clinical pharmacologist with extensive experience in planning, designing, execution and interpretation of clinical studies (prospective, retrospective, interventional and observational) in the area of, cancer, cardiovascular and infectious diseases. He was part of successful team which developed first Indian liposomal amphotericin B (Fungisome TM) which is launched in Indian market.

Dr. Jadhav has over twenty-five peer-reviewed publications, co-edited a book, have made numerous posters and oral presentations internationally.

Dr. Jadhav received his PhD in Pharmaceutics from Bombay College of Pharmacy and KEM Hospital at the University of Mumbai, India and did his Post-doctoral Fellowship at the Colleges of Pharmacy and Medicine Univ. of Florida, Gainesville, Florida.